Skip to main content

Kyntra Bio, Inc.

KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000921299

No open-market purchases or sales by Kyntra Bio, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $7.54M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Kyntra Bio, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of KYNB: Q1 2024 compared with Q2 2024
MeasureQ1 2024Of which not filed for Q2 2024Q2 2024Change
Holders1111102−8
Shares61.3M90056.5M−4.78M (−7.8%)
Value$143.9M$2.00K$50.4M−$93.5M (−64.9%)

1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Kyntra Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to KYNB in Q2 2024
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP1,326,336$1.18M0.08%
Susquehanna International Group, LLP483,100$431.1K0.00%
XTX Topco Ltd475,716$424.5K0.04%
Y-Intercept (Hong Kong) Ltd329,479$294.0K0.02%
Centiva Capital, LP185,800$165.8K0.01%
HRT Financial LP179,126$159.0K0.00%
Squarepoint Ops LLC162,914$145.4K0.00%
Point72 Asia (Singapore) Pte. Ltd.145,368$129.7K0.03%
Franklin Street Advisors Inc100,000$89.0K0.01%
Verition Fund Management LLC95,004$84.8K0.00%
Caption Management, LLC90,600$80.8K0.01%
Graham Capital Management, L.P.89,973$80.3K0.00%
Northeast Financial Consultants Inc54,699$48.8K0.00%
Mirae Asset Global ETFs Holdings Ltd.47,183$42.1K0.00%
Connor, Clark & Lunn Investment Management Ltd.29,063$25.9K0.00%
Catalyst Funds Management Pty Ltd23,700$21.1K0.01%
Balyasny Asset Management LLC19,393$17.3K0.00%
Jump Financial, LLC14,496$12.9K0.00%
GFG Capital, LLC12,830$11.4K0.00%
Victory Capital Management Inc11,942$10.7K0.00%
JustInvest LLC10,488$9.36K0.00%
Macquarie Group Ltd4,647$4.15K0.00%
SRS Capital Advisors, Inc.3,681$3.29K0.00%
Lazard Asset Management LLC4,127$3.00K0.00%
Larson Financial Group LLC500$4460.00%

Sold out (33)

Institutions that held Kyntra Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Not filed for Q2 2024 yet (1)

Institutions that held Kyntra Bio, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KYNB in Q1 2024 that haven't filed for Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Cutler Group LP900$2.00K